logo
Select company
Select metric
$ -15.79MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
72
Sector
89
Industry
97
History
100
$ 2.21Close
$ 1.66 - $ 2.55 52-Week Range
Ticker Information

Ticker

SEER

Company Name

SEER INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SEER INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SEER - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ -15.79M
3/31/2025$ -12.17M
12/31/2024$ -11.49M
9/30/2024$ -10.05M
6/30/2024$ -3.39M
3/31/2024$ 422K
12/31/2023$ 452K
9/30/2023$ 2.38M
6/30/2023$ 2.52M
3/31/2023$ 3.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SEER INC's latest trailing twelve months (TTM) CF - Equity stands at $ 316.59M.
  • Over the past 5 years, SEER INC's average CF - Equity has been $ 47.68M.
  • The median CF - Equity for SEER INC during this period was $ 2.38M
  • SEER INC reached its highest CF - Equity over the past 5 years at $ 419.98M.
  • The lowest CF - Equity recorded by SEER INC in the same timeframe $ -15.79M

SEER INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
HYFT : MINDWALK HOLDINGS CORP $ 8.47MIRD : OPUS GENETICS INC $ 22.07MEQ : EQUILLIUM INC $ 148KVRCA : VERRICA PHARMACEUTICALS INC $ 39.64MFATE : FATE THERAPEUTICS INC $ 0BRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 1.3MWHWK : WHITEHAWK THERAPEUTICS INC $ 94.48MSRZN : SURROZEN INC $ 71.35MCRVO : CERVOMED INC $ -13.34KTCRX : TSCAN THERAPEUTICS INC $ 1.8M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

SEER - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -15.79M

Minimum

Jun 30, 2025

$ 419.98M

Maximum

Sep 30, 2021

$ 47.68M

Average

$ 2.38M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 130.54K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 130.54K
median$ 0
std$ 17.65M